Amgen Inc
AMGN·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$435.86
Today
-0.7%
YTD
+32.8%
About
Amgen Inc. is a healthcare company that develops and manufactures innovative human therapeutics designed to address health issues such as cancer and cardiovascular diseases. Founded in 1980 and headquartered in Thousand Oaks, California, the company operates worldwide. It trades using the ticker AMGN on the NASDAQ. Add this instrument to your eToro watchlist to stay updated on AMGN price indicators and trends.
Price chart
Closing price history for AMGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)25.03
P/S (TTM)5.74
P/B (TTM)18.64
Market cap$217.86B
Cap tierMega-cap
Industry avg P/E-2.47
Profitability
Gross margin72.71%
EBIT margin33.31%
Net margin23.59%
ROE91.47%
ROA9.53%
Earnings & Revenue
Revenue (TTM)$38.20B
Revenue growth (1Y)+9.9%
EPS (TTM)$16.10
Free cash flow$10.18B
Total debt$57.30B
Dividends & Risk
Dividend rate$9.94
Dividend yield2.47%
Ex-date15 May '26
Beta (5Y)0.53
Employees31,500
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.